Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
3
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
3
×
wisconsin blog main
wisconsin top stories
aducanumab
alzheimer's disease
cancer
crispr
digital health
fda
gene therapy
gilead sciences
glaxosmithkline
ipo
medicare
What
bio
new
3
×
roundup
ipo
remains
activity
allogene
approval
approvals
biogen
biogen’s
biopharmaceutical
cancer
clamped
companies
convo
covid
crispr
delays
developing
diversity
drug
earlier
economic
failures
fast
fda
hot
immunotherapy
including
investors
isn’t
juno
littered
lot
medicines
million
nash
nearly
news
Language
unset
Current search:
biogen
×
new
×
" texas top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More